NM_012199.5:c.1833+258T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_012199.5(AGO1):​c.1833+258T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 152,126 control chromosomes in the GnomAD database, including 13,403 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 13403 hom., cov: 32)

Consequence

AGO1
NM_012199.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.37

Publications

18 publications found
Variant links:
Genes affected
AGO1 (HGNC:3262): (argonaute RISC component 1) This gene encodes a member of the argonaute family of proteins, which associate with small RNAs and have important roles in RNA interference (RNAi) and RNA silencing. This protein binds to microRNAs (miRNAs) or small interfering RNAs (siRNAs) and represses translation of mRNAs that are complementary to them. It is also involved in transcriptional gene silencing (TGS) of promoter regions that are complementary to bound short antigene RNAs (agRNAs), as well as in the degradation of miRNA-bound mRNA targets. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study showed this gene to be an authentic stop codon readthrough target, and that its mRNA could give rise to an additional C-terminally extended isoform by use of an alternative in-frame translation termination codon. [provided by RefSeq, Nov 2015]
AGO1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.771 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012199.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGO1
NM_012199.5
MANE Select
c.1833+258T>C
intron
N/ANP_036331.1Q9UL18
AGO1
NM_001317122.2
c.1833+258T>C
intron
N/ANP_001304051.1A0A6I8PTZ8
AGO1
NM_001317123.2
c.1608+258T>C
intron
N/ANP_001304052.1Q5TA58

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGO1
ENST00000373204.6
TSL:1 MANE Select
c.1833+258T>C
intron
N/AENSP00000362300.4Q9UL18
AGO1
ENST00000674426.1
c.1833+258T>C
intron
N/AENSP00000501372.1A0A6I8PTZ8
AGO1
ENST00000931711.1
c.1833+258T>C
intron
N/AENSP00000601770.1

Frequencies

GnomAD3 genomes
AF:
0.340
AC:
51725
AN:
152008
Hom.:
13360
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.666
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.382
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.792
Gnomad SAS
AF:
0.321
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.314
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.341
AC:
51836
AN:
152126
Hom.:
13403
Cov.:
32
AF XY:
0.346
AC XY:
25707
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.666
AC:
27640
AN:
41482
American (AMR)
AF:
0.383
AC:
5856
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
738
AN:
3468
East Asian (EAS)
AF:
0.792
AC:
4098
AN:
5176
South Asian (SAS)
AF:
0.320
AC:
1544
AN:
4824
European-Finnish (FIN)
AF:
0.181
AC:
1917
AN:
10568
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9181
AN:
68006
Other (OTH)
AF:
0.314
AC:
663
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1291
2582
3874
5165
6456
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.190
Hom.:
6336
Bravo
AF:
0.374
Asia WGS
AF:
0.523
AC:
1813
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.16
DANN
Benign
0.60
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs595055; hg19: chr1-36380133; API